What is Brimonidine 0.33% Erythego® Gel 15g [Mirvaso Generic]
Erythego® Gel 15g is manufactured by reputable Akumentis Healthcare Ltd company. Erythego contains the main active ingredient Brimonidine 0.33%. Erythego® Gel is an alternative/analog/generic of Mirvaso® (brimonidine) topical gel, 0.33%, is the FDA-approved treatment developed and indicated for persistent (nontransient) facial redness of rosacea. Facial redness is a common symptom of rosacea, a skin condition that affects an estimated 100 million people around the globe. Erythego® Gel is a temporary treatment for facial redness, may dramatically reduce your symptoms, but it won’t prevent or cure facial redness. Your redness will return after the effect of Erythego Gel wears off. Exposure to triggers could make your symptoms worse Avoid your triggers, even if you are using Erythego Gel as directed.
Erythego Brimonidine topical gel, 0.33% is an alpha adrenergic agonist indicated for the topical treatment of persistent (nontransient) facial erythema of rosacea in adults 18 years of age or older.
Fast results that last up to 12 hours. Get ready for real redness relief: Erythego® (brimonidine) topical gel, 0.33% has been proven to continue to give consistent results, month after month.
Some patients have reported a “worsening” of redness several hours after using Brimonidine topical gel. A small percentage of patients in clinical studies reported that their facial redness returned worse than it appeared before using the gel. This could be caused by a return of the redness to the same level it was prior to using the gel, which can be concerning, especially after seeing “healthy” colored skin. Although this return of redness should go away with additional treatment, if you experience discomfort or have any concerns or questions about using Erythego Gel, contact your doctor.
Side effects of Brimonidine 0.33% Erythego® Gel 15g
In clinical trials, the most common adverse reactions (≥1%) included erythema, flushing, skin burning sensation, and contact dermatitis.
Warnings/Precautions: Erythego Brimonidine 0.33% gel should be used with caution in patients with depression, cerebral or coronary insufficiency, Raynaud’s phenomenon, orthostatic hypotension, thromboangiitis obliterans, scleroderma, or Sjögren’s syndrome.
Alpha-2 adrenergic agents can lower blood pressure. Erythego Brimonidine gel should be used with caution in patients with severe or unstable or uncontrolled cardiovascular disease.
Serious adverse reactions following accidental ingestion of Erythego Brimonidine gel by children have been reported. Keep out of reach of children. Not for oral, ophthalmic, or intravaginal use.
How to use Brimonidine 0.33% Erythego® Gel 15g, a Mirvaso Alternative
In clinical studies with Erythego Gel, the primary endpoint showed rosacea redness was reduced for up to 12 hours for 22% of study participants (versus 9% of people using a gel with no active ingredient [vehicle gel]). The secondary endpoint showed redness was visibly reduced in as little as 30 minutes for 28% of participants (versus 6% of people using the vehicle gel).
Getting the best results with Brimonidine 0.33% Erythego® Gel
What to expect from Erythego Gel. For most patients, the Erythego Gel effect is powerful. Skin that has been red for days, months, or even years may suddenly look “normal” again. But remember: Erythego Gel is not a cure for rosacea, your redness will return after the effect of the medication wears off.
Some patients have reported that their redness returned worse than it appeared before. This could be due to exposure to triggers or it may simply be a return to your natural complexion, which may be alarming after seeing yourself without the usual redness. Common triggers include: spicy food; stress and anxiety; hot drinks, such as coffee and tea; alcohol, such as red wine; physical activity, such as exercise; sun exposure; extreme hot or cold environments; and certain skin-care products. Avoid your triggers, even while you are using Erythego gel.
Tell your doctor about side effects. In clinical trials, about 10% of subjects reported worsening of redness while using the gel. In every case, this side effect was temporary and went away on its own. However, if you are concerned that you may be experiencing a side effect while using Erythego Gel, speak to your physician or dermatologist right away.
What Is Rosacea?
Rosacea is a common vascular and inflammatory facial skin condition. People with fair skin over age 30 are more likely to get rosacea, but it can affect people of any age, from any background.
Facial redness and rosacea. The facial redness of rosacea, also called erythema (err-uh-thee-ma), is a common rosacea symptom—and may be the only symptom for some people. A 2012 Gallup survey asked 510 people with rosacea which symptoms they were currently experiencing and found that facial redness was by far the most common:
- Facial redness 87%
- Facial skin sensitivity to sun 51%
- Small, thin, red lines below surface of the skin 42%
- Facial burning sensation 40%
- Pimples/pustules without blackheads 39%
- Eye redness and irritation 31%
- Pimples/pustules with blackheads 15%
- Enlarged nose or swollen bumps on the nose 14%
You might find that certain things set off your redness. Avoiding known triggers may help you manage your symptoms